BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25133190)

  • 1. Compensatory mechanisms of pancreatic beta cells: insights into the therapeutic perspectives for diabetes.
    Regazzi R; Dalle S; Abderrahmani A
    J Diabetes Res; 2014; 2014():217387. PubMed ID: 25133190
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic potential of pancreatic PAX4-regulated pathways in treating diabetes mellitus.
    Lorenzo PI; Cobo-Vuilleumier N; Gauthier BR
    Curr Opin Pharmacol; 2018 Dec; 43():1-10. PubMed ID: 30048825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide 1-potentiated insulin secretion and proliferation of pancreatic β-cells.
    Ma X; Guan Y; Hua X
    J Diabetes; 2014 Sep; 6(5):394-402. PubMed ID: 24725840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin Therapy, Insulin Resistance and Vascular Dysfunction.
    Vázquez MC; Sobrevia L
    Curr Vasc Pharmacol; 2019; 17(5):429-431. PubMed ID: 31418345
    [No Abstract]   [Full Text] [Related]  

  • 5. MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic β-cells.
    Wang Y; Liu J; Liu C; Naji A; Stoffers DA
    Diabetes; 2013 Mar; 62(3):887-95. PubMed ID: 23223022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting protein misfolding to protect pancreatic beta-cells in type 2 diabetes.
    Costes S
    Curr Opin Pharmacol; 2018 Dec; 43():104-110. PubMed ID: 30245473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP.
    Thielen L; Shalev A
    Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):75-80. PubMed ID: 29356688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-Based Methods to Identify Inducers of Human Pancreatic Beta-Cell Proliferation.
    Ackeifi CA; Swartz EA; Wang P
    Methods Mol Biol; 2018; 1787():87-100. PubMed ID: 29736712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Should we consider a new classification of diabetes influenced by therapeutic decisions?].
    Škrha J
    Vnitr Lek; 2016; 62(11 Suppl 4):S113-118. PubMed ID: 27921435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD36 Signal Transduction in Metabolic Diseases: Novel Insights and Therapeutic Targeting.
    Karunakaran U; Elumalai S; Moon JS; Won KC
    Cells; 2021 Jul; 10(7):. PubMed ID: 34360006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review on Molecular Mechanism of Flavonoids as Antidiabetic Agents.
    Jasmin ; Jaitak V
    Mini Rev Med Chem; 2019; 19(9):762-786. PubMed ID: 30588881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic β cells: Gatekeepers of type 2 diabetes.
    Park YJ; Woo M
    J Cell Biol; 2019 Apr; 218(4):1094-1095. PubMed ID: 30696700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension, Diabetes and Neurodegenerative Diseases: Is there a Clinical Link through the Ca2+/cAMP Signalling Interaction?
    Bergantin LB
    Curr Hypertens Rev; 2019; 15(1):32-39. PubMed ID: 30117399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiabetic potential of saffron and its active constituents.
    Yaribeygi H; Zare V; Butler AE; Barreto GE; Sahebkar A
    J Cell Physiol; 2019 Jun; 234(6):8610-8617. PubMed ID: 30515777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological regulation of the pancreatic {beta}-cell: functional insights for understanding and therapy of diabetes.
    McClenaghan NH
    Exp Physiol; 2007 May; 92(3):481-96. PubMed ID: 17272356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic beta-cell signaling: toward better understanding of diabetes and its treatment.
    Seino S; Shibasaki T; Minami K
    Proc Jpn Acad Ser B Phys Biol Sci; 2010; 86(6):563-77. PubMed ID: 20551594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early insulinization to prevent diabetes progression.
    Raz I; Mosenzon O
    Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S190-7. PubMed ID: 23882045
    [No Abstract]   [Full Text] [Related]  

  • 18. Transient receptor potential (TRP) cation channels in diabetes.
    Colsoul B; Nilius B; Vennekens R
    Curr Top Med Chem; 2013; 13(3):258-69. PubMed ID: 23432059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [112th Scientific Meeting of the Japanese Society of Internal Medicine: Presidential Lecture: Panel discussion: Preemptive Medicine for Diabetes Mellitus].
    Inagaki N; Fujita N; Kimura H; Hamamatsu K; Sano K; Hirai M; Murakami A; Saji H; Fujimoto H
    Nihon Naika Gakkai Zasshi; 2015 Sep; 104(9):1803-7. PubMed ID: 30160872
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular aspects of pancreatic beta cell failure and diabetes.
    Arvan P; Bernal-Mizrachi E; Liu M; Pietropaolo M; Satin L; Schnell S; Soleimanpour SA
    Mol Aspects Med; 2015 Apr; 42():1-2. PubMed ID: 25596327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.